SERD

AstraZeneca beats Roche twice in a day
EP Vantage
Wed, 10/26/22 - 10:20 am
AstraZeneca
Roche
SERD
breast cancer
Ipatasertib
capivasertib
Camizestrant
Olema Oncology previews Phase III trial plans for dual-mechanism SERD in breast cancer
Clinical Trials Arena
Fri, 09/23/22 - 10:57 am
Olema Oncology
SERD
breast cancer
As Sanofi's SERD falls, Menarini’s advances with EU review
Fierce Biotech
Fri, 08/19/22 - 10:42 am
Sanofi
Menarini
Europe
SERD
breast cancer
elacstrant
Sanofi scraps oral SERD strategy after 2nd failure in breast cancer
Fierce Biotech
Wed, 08/17/22 - 10:50 am
Sanofi
SERD
breast cancer
clinical trials
Roche’s oral SERD giredestrant fails breast cancer trial
Pharmaforum
Mon, 04/25/22 - 10:48 am
Roche
breast cancer
SERD
Giredestrant
clinical trials